-AbstractBackground: Type 2 diabetes is characterized by impaired insulin secretion and/or insulin resistance. Thiazolidinediones have been shown to ameliorate insulin resistance. The purpose of the present study was to evaluate the long term serial effect of pioglitazone on anthropometrics and metabolic parameters in Korean type 2 diabetes patients. Methods: One hundred thirteen type 2 diabetes patients (male, 67; female, 46; mean age, 49.1 ± 10.8 years) were evaluated before and after 3 months, 6 months and 12 months of treatment with pioglitazone (Actos
Data are expressed as means ± SD.; BMI, body mass index; WHR, waist to hip circumference ratio; HbA1c, glycosylated hemoglobin; FPg, fasting plasma glucose; HDL, high density lipoprotein; LDL, low density lipoprotein; AST, aspartate transaminase; ALT, alanine transaminase; HOMA-IR, homeostasis model assessment insulin resistanace; SFT, subcutaneous fat thickness; VFT, visceral fat thickness; VSR, the ratio of VFT to SFT; SU, sulfonylurea. * P < 0.05 male versus female. -month, multicenter, double -blind, randomized, controlled, parallel-group trial. Clin Ther 26:744-54, 2004 14 
